Yunnan Botanee Bio-Technology Group Co Ltd (300957) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥125.55 Million ≈ $18.37 Million USD) by net assets (CN¥6.22 Billion ≈ $910.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Yunnan Botanee Bio-Technology Group Co L defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Yunnan Botanee Bio-Technology Group Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yunnan Botanee Bio-Technology Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Netac Tech
SHE:300042
|
-0.110x |
|
Wankai New Materials Co. Ltd.
SHE:301216
|
N/A |
|
Zhejiang Semir Garment Co Ltd
SHE:002563
|
-0.018x |
|
Capri Holdings Ltd
NYSE:CPRI
|
1.874x |
|
Northwest Natural Gas Co
NYSE:NWN
|
0.074x |
|
Turpaz Industries Ltd
TA:TRPZ
|
0.033x |
|
Bure Equity AB
ST:BURE
|
-0.006x |
|
Tibet Urban Development and Investment Co Ltd
SHG:600773
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Yunnan Botanee Bio-Technology Group Co L.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.30 Billion ≈ $922.55 Million |
CN¥976.60 Million ≈ $142.91 Million |
0.155x | +37.94% |
| 2024-12-31 | CN¥6.19 Billion ≈ $905.47 Million |
CN¥694.87 Million ≈ $101.68 Million |
0.112x | +10.67% |
| 2023-12-31 | CN¥6.02 Billion ≈ $880.30 Million |
CN¥610.44 Million ≈ $89.33 Million |
0.101x | -26.12% |
| 2022-12-31 | CN¥5.60 Billion ≈ $819.80 Million |
CN¥769.45 Million ≈ $112.59 Million |
0.137x | -43.07% |
| 2021-12-31 | CN¥4.78 Billion ≈ $699.24 Million |
CN¥1.15 Billion ≈ $168.68 Million |
0.241x | -32.74% |
| 2020-12-31 | CN¥1.20 Billion ≈ $175.86 Million |
CN¥431.03 Million ≈ $63.07 Million |
0.359x | -46.99% |
| 2019-12-31 | CN¥761.02 Million ≈ $111.36 Million |
CN¥514.92 Million ≈ $75.35 Million |
0.677x | +198.51% |
| 2018-12-31 | CN¥450.87 Million ≈ $65.98 Million |
CN¥102.20 Million ≈ $14.95 Million |
0.227x | -70.62% |
| 2017-12-31 | CN¥262.44 Million ≈ $38.40 Million |
CN¥202.44 Million ≈ $29.62 Million |
0.771x | -- |
About Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup … Read more